K. Bae

Evaluation of nuclear factor κB and chemokine receptor CXCR4 co‐expression in patients with prostate cancer in the Radiation Therapy Oncology Group (RTOG) 8610

H. Sandler, Liang Cheng, A. Dicker, 2011, BJU international.

Confirmation of a low α/β ratio for prostate cancer treated by external beam radiation therapy alone using a post-treatment repeated-measures model for PSA dynamics.

L. Kestin, H. Sandler, T. Pickles, 2011, International journal of radiation oncology, biology, physics.

Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analy

K. Pienta, H. Sandler, J. Michalski, 2009, International journal of radiation oncology, biology, physics.

Late toxicity and biochemical recurrence after external‐beam radiotherapy combined with permanent‐source prostate brachytherapy

H. Sandler, M. Kuettel, M. Gillin, 2007, Cancer.

Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02.

W. Shipley, G. Hanks, C. Lawton, 2008, International journal of radiation oncology, biology, physics.

Real‐Time Individual Predictions of Prostate Cancer Recurrence Using Joint Models

Yongseok Park, Donna P Ankerst, Tom Pickles, 2013, Biometrics.

Confirmation of a low α/β ratio for prostate cancer treated by external beam radiation therapy alone using a post-treatment repeated-measures model for PSA dynamics.

L. Kestin, H. Sandler, T. Pickles, 2011, International Journal of Radiation Oncology, Biology, Physics.

Confirmation of a low α/β ratio for prostate cancer treated by external beam radiation therapy monotherapy using a post-treatment repeated measures model for PSA dynamics

L. Kestin, S. Secher, K. Bae, 2011 .